The present invention relates to a pharmaceutical compositions or its pharmaceutically acceptable salt including amorphous lenalidomide, have a synthetized oxidation preventive agent and one or more pharmaceutically acceptable excipients. The invention further relates to processes as a medicament, especially to manufacture this composition in the treatment in the treatment of Hupperts disease and myelodysplastic syndrome and use the synthetic.
